Epidemiology of Ovarian Cancer in Taiwan
|ClinicalTrials.gov Identifier: NCT01465750|
Recruitment Status : Unknown
Verified April 2011 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : November 7, 2011
Last Update Posted : November 7, 2011
|Condition or disease|
Study population: To evaluate the epidemiology and prognosis of ovarian cancer in Taiwan, we will conduct a nationwide analysis through linking national cancer registry database. Every citizen in Taiwan has a life-long identification number to link individual information, including health status. The Taiwan household registry database provided by Department of Health will be the source population. National household registry and death certificate will be adopted to ascertain the live status of study subjects, and provided individual demographic characteristics.All individual linkages between databases will be conducted according to the study protocols, i.e. databases will be linked by corresponding identification number, name (Chinese characters) and birthday, and all data included in this study will be analyzed without individual identification information. The agreement of utilizing the databases in the study was obtained from the Bureau of Health Promotion in Taiwan.
Incident and death cases ascertainment: Patients with ovarian cancer, including epithelial ovarian carcinoma, germ cell tumors, sex cord tumors … etc., will be identified from computerized linkage to the Taiwan national cancer registry with International Classification of Diseases for Oncology Third Edition T-code C569. Histological types will be identified from morphology code in the cancer registry database. Women affected by ovarian cancer and found death due to ovarian cancer (International Classification of Diseases 9th edition code 183) in deaths certificate will be defined as death cases.
Statistical Analyses: The numbers of person-years at risk of developing and dying for ovarian cancer will be calculated. Incidence rates will be calculated by dividing the number of ovarian cancer cases by the person-years at risk of developing ovarian cancer. Mortality rates will be calculated by dividing the number of ovarian cancer deaths by the person-years at risk of dying from ovarian cancer. The association between mortality and age, histology, time periods will be estimated through Kaplan-Meier survival analysis and Cox's proportional hazards model. It is defined as significantly different statistically when p value is less than 0.05.
|Study Type :||Observational|
|Estimated Enrollment :||10000 participants|
|Official Title:||Epidemiology of Ovarian Cancer in Taiwan|
|Study Start Date :||April 2011|
|Estimated Primary Completion Date :||April 2012|
|Estimated Study Completion Date :||April 2014|
- Overall survival [ Time Frame: From diagnosis of ovarian cancer to death or last date of linked data available from the Taiwan Cancer Registry or Death Certification Profile ]The follow-up of each participant (in personyears) was calculated from the date of enrollment to the date of ovarian cancer diagnosis, date of death, or last date of linked data available from the Taiwan Cancer Registry or Death Certification Profile, whichever came first until December 31, 2010.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01465750
|Contact: Wen-Fang Cheng, Professor||886-2-23123456 ext email@example.com|
|National Taiwan University Hospital||Recruiting|
|Contact: Wen-Fang Cheng, Professor 886-2-23123456 ext 71964 firstname.lastname@example.org|
|Principal Investigator:||Wen-Fang Cheng, Professor||National Taiwan University Hospital|